Follow the people · Insider
Nikhil Lalwani
Nikhil Lalwani files insider transactions with the SEC as a president & ceo of Ani Pharmaceuticals (ANIP). We hold 2 disclosed purchases and sales filed since 10 September 2020, 1 of them in the last 90 days.
- Files forANIP
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure26 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 September 2020 — 25 August 2026President & CEO · Ani Pharmaceuticals (ANIP)53 Form 4 lines · source: SEC Form 4
Everything they disclosed
53 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 5,400 shares of Ani PharmaceuticalsSEC Form 426 August 2026Common Stock · traded 25 August 2026 · filed 26 August 2026
- ▼ sold on the open market 55,000 shares of Ani PharmaceuticalsSEC Form 413 May 2026Common Stock · traded 11 May 2026 · filed 13 May 2026
- had shares withheld for tax on 17,060 shares of Ani PharmaceuticalsSEC Form 410 March 2026Common Stock · traded 7 March 2026 · filed 10 March 2026
- had shares withheld for tax on 17,060 shares of Ani PharmaceuticalsSEC Form 410 March 2026Common Stock · traded 7 March 2026 · filed 10 March 2026
- was granted 75,592 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 12,217 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- was granted 75,592 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 12,217 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 11,688 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- had shares withheld for tax on 10,298 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 14 February 2026 · filed 17 February 2026
- had shares withheld for tax on 11,688 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- had shares withheld for tax on 10,298 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 14 February 2026 · filed 17 February 2026
- had shares withheld for tax on 30,659 shares of Ani PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- had shares withheld for tax on 30,659 shares of Ani PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- ▼ sold on the open market 56,960 shares of Ani PharmaceuticalsSEC Form 414 August 2025Common Stock · traded 12 August 2025 · filed 14 August 2025
- had shares withheld for tax on 17,455 shares of Ani PharmaceuticalsSEC Form 425 March 2025Common Stock · traded 23 March 2025 · filed 25 March 2025
- had shares withheld for tax on 17,060 shares of Ani PharmaceuticalsSEC Form 414 March 2025Common Stock · traded 7 March 2025 · filed 14 March 2025
- had shares withheld for tax on 12,216 shares of Ani PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 28 February 2025 · filed 4 March 2025
- was granted 91,399 shares of Ani PharmaceuticalsSEC Form 418 February 2025Common Stock · traded 12 February 2025 · filed 18 February 2025
- was granted 60,932 shares of Ani PharmaceuticalsSEC Form 418 February 2025Common Stock · traded 12 February 2025 · filed 18 February 2025
- had shares withheld for tax on 7,799 shares of Ani PharmaceuticalsSEC Form 418 February 2025Common Stock · traded 14 February 2025 · filed 18 February 2025
- exercised options over 30,000 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 427 November 2024Stock Option (right to buy) · traded 26 November 2024 · filed 27 November 2024
- exercised options over 30,000 shares of Ani PharmaceuticalsSEC Form 427 November 2024Common Stock · traded 26 November 2024 · filed 27 November 2024
- ▼ sold on the open market 30,000 shares of Ani PharmaceuticalsSEC Form 427 November 2024Common Stock · traded 26 November 2024 · filed 27 November 2024
- ▼ sold on the open market 3,481 shares of Ani PharmaceuticalsSEC Form 427 November 2024Common Stock · traded 26 November 2024 · filed 27 November 2024
- had shares withheld for tax on 3,646 shares of Ani PharmaceuticalsSEC Form 410 September 2024Common Stock · traded 8 September 2024 · filed 10 September 2024
- ▼ sold on the open market 16,669 shares of Ani PharmaceuticalsSEC Form 416 May 2024Common Stock · traded 14 May 2024 · filed 16 May 2024
- had shares withheld for tax on 17,455 shares of Ani PharmaceuticalsSEC Form 425 March 2024Common Stock · traded 23 March 2024 · filed 25 March 2024
- ▼ sold on the open market 28,965 shares of Ani PharmaceuticalsSEC Form 48 March 2024Common Stock · traded 6 March 2024 · filed 8 March 2024
- had shares withheld for tax on 17,060 shares of Ani PharmaceuticalsSEC Form 48 March 2024Common Stock · traded 7 March 2024 · filed 8 March 2024
- ▼ sold on the open market 16,292 shares of Ani PharmaceuticalsSEC Form 48 March 2024Common Stock · traded 8 March 2024 · filed 8 March 2024
- had shares withheld for tax on 10,014 shares of Ani PharmaceuticalsSEC Form 41 March 2024Common Stock · traded 29 February 2024 · filed 1 March 2024
- was granted 80,530 shares of Ani PharmaceuticalsSEC Form 416 February 2024Common Stock · traded 14 February 2024 · filed 16 February 2024
- was granted 53,686 shares of Ani PharmaceuticalsSEC Form 416 February 2024Common Stock · traded 14 February 2024 · filed 16 February 2024
- had shares withheld for tax on 3,646 shares of Ani PharmaceuticalsSEC Form 411 September 2023Common Stock · traded 8 September 2023 · filed 11 September 2023
- exercised options over 11,616 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 415 August 2023Stock Option (right to buy) · traded 15 August 2023 · filed 15 August 2023
- ▼ sold on the open market 56,666 shares of Ani PharmaceuticalsSEC Form 415 August 2023Common Stock · traded 11 August 2023 · filed 15 August 2023
- exercised options over 11,616 shares of Ani PharmaceuticalsSEC Form 415 August 2023Common Stock · traded 15 August 2023 · filed 15 August 2023
- ▼ sold on the open market 11,616 shares of Ani PharmaceuticalsSEC Form 415 August 2023Common Stock · traded 15 August 2023 · filed 15 August 2023
- was granted 95,530 shares of Ani PharmaceuticalsSEC Form 44 April 2023Common Stock · traded 28 February 2023 · filed 4 April 2023
- was granted 63,686 shares of Ani PharmaceuticalsSEC Form 44 April 2023Common Stock · traded 28 February 2023 · filed 4 April 2023
- had shares withheld for tax on 17,455 shares of Ani PharmaceuticalsSEC Form 427 March 2023Common Stock · traded 23 March 2023 · filed 27 March 2023
- had shares withheld for tax on 9,397 shares of Ani PharmaceuticalsSEC Form 49 March 2023Common Stock · traded 7 March 2023 · filed 9 March 2023
- had shares withheld for tax on 4,265 shares of Ani PharmaceuticalsSEC Form 49 March 2023Common Stock · traded 7 March 2023 · filed 9 March 2023
- had shares withheld for tax on 3,646 shares of Ani PharmaceuticalsSEC Form 412 September 2022Common Stock · traded 8 September 2022 · filed 12 September 2022
- was granted 33,352 shares of Ani PharmaceuticalsSEC Form 429 April 2022Common Stock · traded 27 April 2022 · filed 29 April 2022
- was granted 100,055 shares of Ani PharmaceuticalsSEC Form 428 March 2022Common Stock · traded 24 March 2022 · filed 28 March 2022
- had shares withheld for tax on 17,454 shares of Ani PharmaceuticalsSEC Form 425 March 2022Common Stock · traded 23 March 2022 · filed 25 March 2022
- ▲ bought on the open market 7,224 shares of Ani PharmaceuticalsSEC Form 423 March 2022Common Stock · traded 21 March 2022 · filed 23 March 2022
- had shares withheld for tax on 2,577 shares of Ani PharmaceuticalsSEC Form 410 September 2021Common Stock · traded 8 September 2021 · filed 10 September 2021
- was granted 136,495 shares of Ani PharmaceuticalsSEC Form 425 March 2021Common Stock · traded 23 March 2021 · filed 25 March 2021
- was granted 179,643 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 410 September 2020Stock Option (right to buy) · traded 8 September 2020 · filed 10 September 2020
- was granted 28,508 shares of Ani PharmaceuticalsSEC Form 410 September 2020Common Stock · traded 8 September 2020 · filed 10 September 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.